Scarlet Al-T
Payments companies reported to CMS as associated with Scarlet Al-T. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Scarlet Al-T, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Scarlet Al-T
These are the largest totals companies reported as associated with Scarlet Al-T. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Kapsokavathis | Birmingham, MI | Orthopaedic Surgery of The Spine | $3,008.30 |
| Teja Karukonda | Teaneck, NJ | Orthopaedic Surgery | $2,224.28 |
| John Younghein | Stoneham, MA | Orthopaedic Surgery | $2,200.53 |
| Brian Su | Larkspur, CA | Orthopaedic Surgery of The Spine | $1,438.80 |
| Eren Kuris | East Providence, RI | Orthopaedic Surgery of The Spine | $1,256.46 |
| Steven Spitz | Canton, GA | Neurological Surgery | $1,254.33 |
| Jeremy Denning | Dallas, TX | Neurological Surgery | $1,222.97 |
| Jeffrey Lobel | Lima, OH | Neurological Surgery | $1,178.15 |
| Edward Smith | Hurst, TX | Orthopaedic Surgery | $1,122.29 |
| Pasquale Montesano | Palm Beach Gardens, FL | Orthopaedic Surgery of The Spine | $1,122.29 |
Prescribed Scarlet Al-T?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.